Table 6 Maximum performance results under the second testing scenario; 10-fold cross validation Alon et al. [15] (colon cancer) data set.
From: Outcome prediction based on microarray analysis: a critical perspective on methods
| Â | Filter Method | Wrapper Methods | Hybrid Methods | ||||||
|---|---|---|---|---|---|---|---|---|---|
Criterion | Fisher's Ratio | RFE-LNW-GD | RFE-SVM | RFE-LSSVM | RFE-RR | RFE-FLDA | RFE-LNW1 | RFE-LNW2 | RFE-FSVs-7DK |
Accuracy | 0.90 | 0.87 | 0.87 | 0.91 | 0.83 | 0.89 | 0.91 | 0.89 | 0.91 |
Sensitivity, Specificity | 0.92, 0.88 | 0.89, 0.85 | 0.92, 0.79 | 0.97, 0.81 | 0.77, 0.91 | 0.93, 0.84 | 0.93, 0.88 | 0.93, 0.84 | 0.93, 0.89 |
Confidence Interval | 0.25 | 0.29 | 0.29 | 0.22 | 0.31 | 0.26 | 0.22 | 0.26 | 0.24 |
Number of genes selected | 16 | 17 | 16 | 22 | 19 | 14 | 10 | 15 | 12 |